The introduction of prostate cancer screening by PSA played a significant role in increasing the diagnoses of prostate cancer in its early stages during the 2000s and early 2010s, reflected in our findings as a declining mortality rate. The gene discussed is KLK3; the disease is Familial prostate cancer.